351
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Canakinumab for treatment of cryopyrin-associated periodic syndrome

&
Pages 1631-1636 | Published online: 19 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ogugua Ndili Obi, Elyse E. Lower & Robert P. Baughman. (2021) Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Review of Clinical Pharmacology 14:2, pages 179-210.
Read now
Jangwon Heo, Yasir J Sepah, Jithin Yohannan, Morgan Renner, Abeer Akhtar, Anthony Gregory, Mathew Shulman, Diana V Do & Quan Dong Nguyen. (2012) The role of biologic agents in the management of non-infectious uveitis. Expert Opinion on Biological Therapy 12:8, pages 995-1008.
Read now
Gloria López-Castejón & Pablo Pelegrín. (2012) Current status of inflammasome blockers as anti-inflammatory drugs. Expert Opinion on Investigational Drugs 21:7, pages 995-1007.
Read now
Theresa Larson, Robert B Nussenblatt & H Nida Sen. (2011) Emerging drugs for uveitis. Expert Opinion on Emerging Drugs 16:2, pages 309-322.
Read now

Articles from other publishers (8)

Anna A. Zayaeva, Lyudmila V. Sokolova, Denis V. Shaduro, Andrey V. Petrov, Shanmugaraj Kulanthaivel & Vitalii B. Kaliberdenko. (2022) Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report. Current Rheumatology Reviews 18:4, pages 373-379.
Crossref
Stylianos Tomaras, Carl Christoph Goetzke, Tilmann Kallinich & Eugen Feist. (2021) Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach. Journal of Clinical Medicine 10:4, pages 733.
Crossref
Yiming Xu, Matteo Scipioni, Hallie Blevins & Shijun Zhang. (2021) Structural insights of sulfonamide-based NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization. Medicinal Chemistry Research 30:2, pages 473-482.
Crossref
Musaddique Hussain, Chengyun Xu, Mashaal Ahmad, Abdul Majeed, Meiping Lu, Xiling Wu, Lanfang Tang & Ximei Wu. (2018) Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development. Clinical Pharmacology & Therapeutics 104:3, pages 484-494.
Crossref
Amma Owusu-Ansah, Chibueze A. Ihunnah, Aisha L. Walker & Solomon F. Ofori-Acquah. (2016) Inflammatory targets of therapy in sickle cell disease. Translational Research 167:1, pages 281-297.
Crossref
SeungHye Han & Rama K. Mallampalli. (2015) The Acute Respiratory Distress Syndrome: From Mechanism to Translation. The Journal of Immunology 194:3, pages 855-860.
Crossref
Toshio Heike, Megumu K Saito, Ryuta Nishikomori, Takahiro Yasumi & Tatsutoshi Nakahata. (2011) Autoinflammatory diseases - a new entity of inflammation. Inflammation and Regeneration 31:2, pages 125-136.
Crossref
Simon M. Mueller, Peter Itin & Peter Haeusermann. (2011) Muckle-Wells Syndrome Effectively Treated with Canakinumab: Is the Recommended Dosing Schedule Mandatory?. Dermatology 223:2, pages 113-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.